Mechanisms of androgen receptor-centered transcriptional networks in regulating cd8+ t cell exhaustion and therapeutic applications in cancer
US-2024382459-A1 · Nov 21, 2024 · US
US10993934B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10993934-B2 |
| Application number | US-201816485152-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2018 |
| Priority date | Jul 11, 2017 |
| Publication date | May 4, 2021 |
| Grant date | May 4, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a composition for topical application for preventing hair loss, androgenic alopecia (AA) and stimulating hair growth having dutasteride. The composition for topical application for preventing hair loss and stimulating hair growth according to the present invention provides equal or superior hair loss prevention and hair growth stimulating effects while using much smaller dosage than the conventional compositions (oral dosage form) which use finasteride and dutasteride.
Opening claim text (preview).
We claim: 1. A composition for topical application for preventing hair loss and stimulating hair growth, the composition consisting of (a) about 0.022 wt % (equivalent to 0.02% w/v) of dutasteride, (b) about 30 wt % of medium chain triglycerides, (c) about 30 wt % of ethanol and (d) about 40 wt % of castor oil based on total weight of the composition, wherein dutasteride contained in the composition is in an amount to provide a daily dose of about 0.1 to about 0.5 mg.
Preparations for affecting hair growth · CPC title
for baldness or alopecia · CPC title
Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14) · CPC title
Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.